Results

1–2 of 2 results for Aaron Nagiel

A Multicenter Post-Authorization Safety Study of Patients Treated With Voretigene Neparvovec-rzyl Gene Therapy in the United States: Interim Analysis at 3 Years
Aaron Nagiel, MD, PhD
Annual Meeting Talks
2024
Surgical Indications, Outcomes, and Complications of Pediatric Endoscopic Vitrectomy in 285 Consecutive Cases
Aaron Nagiel, MD, PhD
Annual Meeting Talks
2018